Interventional cardiology. Where are we and where are we going from here?;Intervencionismo percutáneo. ¿Dónde estamos y adónde vamos?

Revista Espanola de Cardiologia

Volumn 58, Issue 3, 2005, Pages 290-300

  Pan, Manuel ^a,c   Suárez de Lezo, José ^a   Romero, Miguel ^a   Segura, José ^a   Pavlovic, Djordje ^a   Ojeda, Soledad ^a   Medina, Alfonso ^b   Fernández Dueñas, Jaime ^a   Ariza, Javier ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c Hospital Cruz Roja   (Spain)

Author keywords

Coronary stents; Interventional cardiology; Percutaneous revascularization

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CORONARY STENT; DISEASE SEVERITY; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MEDICAL TECHNOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; CARDIOLOGY; DRUG DELIVERY SYSTEM; FORECASTING; METHODOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVIEW; RISK FACTOR; STENT;

ANGIOPLASTY, BALLOON; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOLOGY; DRUG DELIVERY SYSTEMS; FORECASTING; HUMANS; RISK FACTORS; STENTS;

EID: 17144421537     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13072477     Document Type: Article

References (85)

1. Gruentzig AR. Translumination dilatation of coronary artery stenosis. Lancet. 1978;1:263.
2. Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS, King SB, Gruentzig AR. In hospital morbidity and mortality in patient undergoing elective coronary angioplasty. Circulation. 1985;72:1044-52.
3. Hartzler G. Complex coronary angioplasty: multivessel/multilesion dilatation. En: Ischinger T, editor. Practice of coronary angioplasty. New York: Springer-Verlag; 1986: p. 250-67.
4. Holmes DR, Holubkov R, Vliestra RE. Comparison of complications during PTCA from 1977 to 1981 and from 1985 to 1986: he NHLBI-PTCA Registry. J Am Coll Cardiol. 1988;12:1149-55.
5. Quigley PJ, Erwin J, Maurer BJ, Walsh MJ, Gerty GF. Percutaneous transluminal coronary angioplasty in unstable angina: comparison with stable angina. Br Heart J. 1986;55:227-30.
6. De Feyter PJ, Serruys PW, Van den Brand M, Balakumaran K, Mochtar B, Soward AL, et al. Emergency coronary angioplasty en refractory unstable angina. N Engl J Med. 1985;7:313-42.
7. De Feyter PJ, Serruys PW, Soward A, Van den Brand M, Bos E, Hugenholtz PG. Coronary angioplasty for early postinfarction unstable angina. Circulation. 1986;54:460-5.
8. Myler RK, Shaw RE, Stertzer SH, Bashour TT, Colman Ryan, Hecht HS, et al. Unstable angina and coronary angioplasty. Circulation. 1990;82:1188-95.
9. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol. 1992;19:926-35.
10. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987; 317:581-8.
11. Hinohara T, Rowe MH, Robertson GC, Selmon MR, Braden L, Leggett JH, et al. Effect of lesion characteristics on outcome of directional coronary atherectomy. J Am Coll Cardiol. 1991;17:1112-20.
12. Suárez de Lezo J, Romero M, Medina A, Pan M, Pavlovic D, Vaamonde R, et al. Intracoronary ultrosound assessment of directional coronary atherectomy: immediate and follow-up findings. J Am Coll Cardiol. 1993;21:298-307.
13. Medina A, Suárez de Lezo J, Hernández E, Pan M, Ortega JR, Romero M, et al. Serial angiographic observations after successful directional coronary atherectomy. Am Heart J. 1993;125: 1217-20.
14. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Hofling B, Simonton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med. 1993;329:221-7.
15. Simonton CA, Leon MB, Baim DS, Hinohara T, Kent KM, Bersin RM, et al. «Optimal» directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS). Circulation. 1998;97:332-9.
16. Baim DS, Cutlip DE, Sharma SK, Ho KK, Fortuna R, Schreiber TL, et al. Final results of the Balloon vs Optimal Atherectomy Trial (BOAT). Circulation. 1998;97:322-31.
17. López-Palop R, Moreu J, Fernández-Vázquez F, Hernández R. Registro español de hemodinámica y cardiología intervencionista. XIII Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2003). Rev Esp Cardiol. 2004;57:1076-89.
18. Teirstein PS, Warth DC, Haq N, Jenkins NS, McCowan LC, Aubanel-Reidel P, et al. High speed rotational coronary atherectomy for patients with diffuse coronary artery disease. Am Coll Cardiol. 1991;18:1694-701.
19. Popma JJ, Brogan WC, Pichard AD, Satler LF, Kent KM, Mintz GS, et al. Rotational coronary atherectomy of ostial stenosis. Am J Cardiol. 1993;71:436-8.
20. Schatz RA, Baim DS, Leon MB, Ellis SG, Goldberg S, Hirshfeld JW, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation. 1991; 83:148-61.
21. Herrmann HC, Buchbinder M, Clemen MW, Fishman D, Goldberg S, Lion MB, et al. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation. 1992;86:812-9.
22. Haude M, Erbel R, Issa H, Straub U, Rupprecht HJ, Treese N, et al. Subacute thrombotic complications after coronary implantation of Palmaz-Schatz stents. Am Heart J. 1993;126:15-22.
23. Pan M, Suárez de Lezo J, Velasco F, Romero M, Medina A, Segura J, et al. Reduction of thrombotic and hemorrhagic complications after stent implantation. Am Heart J. 1996;132:1119-26.
24. Schömig A, Neumann FJ, Castrati A, Schühlen H, Blasini R, Hadamitzky M, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med. 1996;334:1084-9.
25. Fernández Avilés F, Alonso JJ, Durán JM, Gimeno F, Muñoz JC, Fuente L, et al. Subacute occlusion, bleeding complications, hospital state and restenosis after Palmaz-Schatz coronary stenting under a new antithrombotic regimen. J Am Coll Cardiol. 1996;27:22-9.
26. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995; 91:1676-88.
27. Morice MC, Zemour G, Benveniste E, Biron Y, Bourdonnec C, Faiver R, et al. Intracoronary stenting without coumarin: one month results of a French multicenter study. Cathet Cardiovasc Diagn. 1995;35:1-8.
28. Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994; 331:489-95.
29. Fishman DL, León MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
30. Suárez de Lezo J, Pavlovic DJ, Medina A, Pan M, Cabrera JA, Romero M, et al. Angiographic predictors of neointimal thickening after successful coronary wall healing following percutaneous revascularization. Am Heart J. 1997;133:210-20.
31. Schwartz R. Animal models of human coronary restenosis. En: Topol E, editor. Textbook of interventional cardiology. 2nd ed. Philadelphia: Saunders; 1994. p. 365-81.
32. Romero M, Medina A, Suárez de Lezo J, Pan M, Hernández E, Segura J. Elective stent implantation in acute coronary syndromes induced by thrombus containing lesions. J Am Coll Cardiol. 1996;27:A69.
33. Alfonso F, Rodríguez P, Phillips P, Goicolea J, Hernández R, Pérez-Vizcayno MJ, et al. Clinical and angiographic implications of coronary stenting in thrombus-containing lesions. J Am Coll Cardiol. 1997;29:725-33.
34. Lee MS, Singh V, Wilentz JR, Makkar RR. AngioJet thrombectomy. J Invasive Cardiol. 2004;16:587-91.
35. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB 3rd, Loop FD, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1988;78:486-502.
36. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): executive summary. J Am Coll Cardiol. 2001;37:2215-38.
37. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Penn M, et al, and RAVEL Study Group. Randomized study with the sirolimus-coated bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
38. TIMI-IIIB Trial investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Ischemia. Circulation. 1994;89:1545-56.
39. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Evaluation of platelet IIb/IIIa inhibitor for stenting. Lancet. 1998;352:87-92.
40. Napodano M, Pasquetto G, Sacca S, Cernetti C, Scarabeo V, Pascotto P, et al. Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2003;42:1395-402.
41. Vetrovec GW, Cowley MJ, Wolfgang TC, Ducey KC. Effects of percutaneous transluminal coronary angioplasty on lesion associated branches. Am Heart J. 1985;109:921-5.
42. Meier B. Kissing balloon angioplasty. Am J Cardiol. 1984;54: 918-20.
43. Zack PM, Ischinger T. Experience with a technique for coronary angioplasty of bifurcational lesions. Cathet Cardiovasc Diagn. 1984;10:433-43.
44. Pan M, Suárez de Lezo J, Medina A, Romero M, Hernández E, Segura J, et al. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol. 1999;83:1320-5.
45. Suwaidi J, Berger P, Rihal C, Garrat K, Bell M, Ting H, et al. Immediate and long-term outcome of coronary stent implantation for true bifurcation lesions. J Am Coll Cardiol. 2000;35:929-36.
46. Yamashita T, Nishida T, Adamian MG, Briguori C, Vaghetti M, Corvaja N, et al. Bifurcation lesions: two stents vs one stent- Immediate and follow-up results. J Am Coll Cardiol. 2000;35:1145-51.
47. Pan M, Suárez de Lezo J, Medina A, Romero M, Segura J, Ramírez A, et al. A stepwise strategy for the stent treatment of bifurcated coronary lesions. Cathet Cardiovasc Intervent. 2002;55:50-7.
48. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109:1244-9.
49. Pan M, Suárez de Lezo J, Medina A, Romero M, Segura J, Pavlovic D, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J. 2004;148:857-64.
50. Tanabe K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F, et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo renarrowings. Am J Cardiol. 2004;94: 115-8.
51. Agrawal SK, Ho DSW, Liu MW, Iyer S, Hearn JA, Cannon AD, et al. Predictors of thrombotic complications after placement of the flexible coil stent. Am J Cardiol. 1994;73:1216-9.
52. Le Breton H, Bedossa M, Commeau P, Boschat J, Huret B, Gilard M, et al. Clinical and angiographic results of stenting for long coronary arterial atherosclerotic lesions. Am J Cardiol. 1998;82:1539-43.
53. Liu M, Luo J, Dean L, Baxley W, Iyer S, Sutor R, et al. Long term follow-up study of coronary reconstruction with multiple stents. Am Heart J. 1999;137:292-7.
54. Di Sciascio G, Patti G, Nasso G, Manzoli A, D'Ambrosio A, Abbate A. Early and long term results of stenting of diffuse coronary artery disease. Am J Cardiol. 2000;86:1166-70.
55. Kornowski R, Bhargava B, Fuchs S, Lansky AJ, Satler LF, Pichard AD, et al. Procedural results and late clinical outcomes after percutaneous interventions using long (> 25 mm) versus short (< 20 mm) stents. J Am Coll Cardiol. 2000;35:612-8.
56. Scheerder IK, Wang K, Kostopoulos K, Dens J, Desmet W, Piessens J. Treatment of long dissections by use of a single long or multiple short stents: clinical and angiographic follow-up. Am Heart J. 1998;136:345-51.
57. Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol. 1999;34:651-9.
58. Colombo A, De Gregorio J, Moussa I, Kobayashi Y, Karvouni E, Di Mario C, et al. Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with provisional spot stenting for treatment of long coronary lesions. J Am Coll Cardiol. 2001; 38:1427-33.
59. Pan M, Suárez de Lezo J, Medina A, Romero M, González S, Segura J, et al. Influence of stent treatment strategies in the long-term outcome of patients with long diffuse coronary lesions. Catheter Cardiovasc Interv. 2003;58:293-300.
60. Hong M, Park S, Mintz G, Lee N, Lee C, Kim J, et al. Intravascular ultrasonic predictors of angiographic restenosis after long coronary stenting. Am J Cardiol. 2000;85:441-5.
61. Degertekin M, Arampatzis CA, Lemos PA, Saia F, Hoye A, Daemen J, et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol. 2004;93:826-9.
62. Romero M, Pan M, Medina A, Suárez de Lezo J, Delgado A, Segura J, et al. Tratamiento de lesiones difusas con stents recubiertos de rapamicina. Rev Esp Cardiol. 2003;56 Supl 2:84.
63. Suero JA, Marso SP, Jones PG, Laster SB, Huber KC, Giorgi LV, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol. 2001;38:409-14.
64. Meier B. Chronic total occlusion. En: Topol E, editor. Textbook of interventional cardiology. 2nd. ed. Philadelphia: Saunders; 1994. p. 318-38.
65. Baim DS, Braden G, Heuser R, Popma JJ, Cutlip DE, Massaro JM, et al. Utility of the Safe-Cross-guided radiofrequency total occlusion crossing system in chronic coronary total occlusions (results from the Guided Radio Frequency Energy Ablation of Total Occlusions Registry Study). Am J Cardiol. 2004;94:853-8.
66. Medina A, Melian F, Suárez de Lezo J, Pan M, Romero M. Effectiveness of coronary stenting for the treatment of chronic total occlusion in angina pectoris. Am J Cardiol. 1994;73:1222-4.
67. Sirnes PA, Golf S, Myreng Y, Molstad P, Albertsson P, Mangschau A, et al. Sustained benefit of stenting chronic coronary occlusion: long-term clinical follow-up of the Stenting in Chronic Coronary Occlusion (SICCO) study. J Am Coll Cardiol. 1998;32: 305-10.
68. Rubartelli F, Niccoli L, Verna E, Giachero C, Zimarino M, Fontanelli A, et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial. Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche. J Am Coll Cardiol. 1998;32:90-6.
69. Buller CE, Dzavik V, Carere RG, Mancini GB, Barbeau G, Lazzam C, et al. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation. 1999;100:236-42.
70. Suárez de Lezo J, Segura J, Medina A, Pan M, Delgado A, Romero M, et al. Recanalized chronic total occlusions covered by sirolimus-eluting stents. Am Coll Cardiol. 2004;43:36.
71. Hoye A, Tanabe K, Lemos PA, Aoki J, Saia F, Arampatzis C, et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J Am Coll Cardiol. 2004;43:1954-8.
72. Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001;38:659-65.
73. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, et al. Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized trial of a distal embolic, protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105: 1285-90.
74. Sim I, Grupta M, McDonald K, Bourassa MG, Hlatky MA. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease. Am J Cardiol. 1995;76:1025-9.
75. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease: long-term CASS experience. Circulation. 1995;91:2325-34.
76. Ferreira AC, Peter AA, Salerno TA, Bolooki H, De Marchena E. Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary case center. Ann Thorac Surg. 2003;75:485-9.
77. Suárez de Lezo J, Pan M, Medina A, Pavlovic D, Romero M, Segura J, et al. Percutaneous cardiopulmonary support in critical patients needing coronary interventions with stents. Cathet Cardiovasc Intervent. 2002;57:467-75.
78. López-Palop R, Pinar E, Saura D, Pérez-Lorente F, Lozano I, Teruel F, et al. Resultados a corto y medio plazo del intervencionismo coronario percutáneo sobre el tronco común izquierdo no protegido en pacientes malos candidatos para revascularización quirúrgica. Rev Esp Cardiol. 2004; 57:1035-44.
79. Suárez de Lezo J, Medina A, Romero M, Hernández E, Pan M, Delgado A, et al. Predictors of restenosis following unprotected left main coronary stenting. Am J Cardiol. 2001;88:308-10.
80. Park SJ, Park SW, Hong MK, Cheong SS, Lee CW, Kim JJ, et al. Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. J Am Coll Cardiol. 1998;31:37-42.
81. Laruelle CJ, Brueren GB, Ernst SM, Bal ET, Mast GE, Suttorp MJ, et al. Stenting of «unprotected» left main coronary artery stenoses: early and late results. Heart. 1998;79:148-52.
82. Hong MK, Park SW, Lee CW, Kang DH, Song JK, Kim JJ, et al. Intravascular ultrasound findings in stenting of unprotected left main coronary artery stenosis. Am J Cardiol. 1998;82:670-3.
83. Silvestri M, Barragan P, Sainsous J, Bayet G, Simeoni JB, Roquebert PO, et al. Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol. 2000;35:1543-50.
84. Suárez de Lezo J, Medina A, Pan M, Delgado A, Segura J, Pavlovic DJ, et al. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. Am Heart J. 2004;148:481-5.
85. Soriano J. Intervencionismo percutáneo en la enfermedad del tronco común izquierdo: ¿es hora de cambiar las guías de actuación? Rev Esp Cardiol. 2004;57:1009-13.